Barbados vs Kazakhstan: Hepatitis B surface antigen (HBsAg) prevalence
Barbados
0.2%
in 2024
Kazakhstan
0.2%
in 2024
Barbados rank
82nd
Kazakhstan rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Barbados
- Kazakhstan
How they compare
Barbados currently reports 0.2% against 0.2% in Kazakhstan, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Barbados ahead.
Barbados ranks 82nd and Kazakhstan ranks 82nd of 194 countries.
Barbados has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Barbados | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.1% | Barbados |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Barbados or Kazakhstan?
- Barbados, at 0.2% against 0.2% in Kazakhstan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Barbados and Kazakhstan?
- 0.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Kazakhstan?
- 10 years are reported by both, from 2015 to 2024.
- How do Barbados and Kazakhstan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Barbados ranks 82nd and Kazakhstan ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.